01911.HK
China Renaissance Holdings Limited
HKSE · Financial Services · Financial - Capital Markets · CN
HKD 3.50
+2.94%Sep 3, 2026, 02:37 UTC
NeuShen Therapeutics announced the completion of an oversubscribed Series B financing round of over $80 million on September 3, 2026.
Source:Aug 27, 2026, 09:15 UTC
China Renaissance Holdings reported interim results for the six months ended June 2026, with net profit of RMB 40.47 million, down 37.7% year-on-year, and revenue of RMB 412 million, down 3.0%.
Source:Aug 17, 2026, 02:00 UTC
Mifeng Technology completed a new round of financing worth hundreds of millions of yuan, led by China Telecom, with Zhangjiang Group following and existing shareholders China Renaissance and Yuanqi Innovation increasing their investments.
Jul 20, 2026, 01:46 UTC
China Renaissance Holdings announced that Liu Taojiang joined the company as Managing Director and Head of Hong Kong Stock Investment Banking.
Source: